Author's reply
- 1*
- 1Int J Cardiol 2010;143:223‑6.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sasmita Biswal
Int J Cardiol 2010;143:223‑6.
Email: drsasmitabiswal@yahoo.in
Copyright: © 2013 The Author(s). This is an open access article.
Abstract
Diagnosis of invasive pulmonary aspergillosis was done in our patient on the basis of isolation of an Aspergillus species from the sputum and from bronchoalveolar lavage samples. Pericardial and myocardial aspergillosis are though rare manifestations of systemic aspergillosis, cardiac involvement by aspergillus species, may result from the contagious spread from the lungs or by the hematogenous route of spread which can also result in arrhythmias and death.[5] Hence, the myocardial ischemic signs and symptoms of our patient might be either due to allergic or hypersensitivity and anaphylactic or anaphylactoid reactions due to the drug or might be a result of disseminated systemic aspergillosis.
Keywords
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026